Haploidentical vs. Sibling, Unrelated, or Cord Blood Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia

Scientists compared overall survival between haploidentical hematopoietic cell transplantation (HCT) using post-transplant cyclophosphamid and HLA-matched sibling donor, 8/8 HLA-matched unrelated donor, 7/8 HLA-matched UD, or umbilical cord blood HCT.